Institutional Investor: Can SoftBank Really Meet Investors' Expectations?

EquityZen

|

August 24, 2018

Company News

Institutional Investor features EquityZen's research on SoftBank's $100 billion Vision Fund in their latest piece.

Related Posts

Company News

EquityZen | December 23, 2015

CNBC: New year, new investing strategy?

EquityZen's managed fund offering is featured by CNBC as a tool for accredited investors to diversify their exposure to...

Company News

EquityZen | April 14, 2021

Yahoo Finance: Coinbase's direct listing and what to expect as a crypto investor

EquityZen's Phil Haslett joins Yahoo Finance to talk crypto, direct listings, and the growth of the pre-IPO market.

Investors Shareholders Insights

EquityZen | July 23, 2024

Pre-IPO Investing | The State Of The Secondary Market

In this video, Phil Haslett, Co-Founder and Chief Strategy Officer of EquityZen, explores the intricacies of the...

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2023 EquityZen. All rights reserved.